Showing results (691-700 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|July 11, 2024
Automated segmentation of brain metastases with deep learning: A multi-center, randomized crossover, multi-reader evaluation studyXiao Luo, Yadi Yang, Shaohan Yin, et al.
Neuro-Oncology|August 31, 2024
The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastomaLiang Zeng, Ying-Qing Li, Shi-Wei He, et al.
Neuro-Oncology|August 19, 2024
Enhancing neuro-oncology care through equity-driven applications of artificial intelligenceMulki Mehari, Youssef Sibih, Abraham Dada, et al.
Neuro-Oncology|June 29, 2024
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomasConnor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, et al.
Neuro-Oncology|June 21, 2024
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directionsJessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, et al.
Neuro-Oncology|June 25, 2024
Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020Kathryn R Tringale, Michael Scordo, Joachim Yahalom, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Neuro-Oncology|June 25, 2024
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastomaMohammad H Abu-Arja, Austin L Brown, Jack M Su, et al.
Neuro-Oncology|May 30, 2024
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapyJosef A Buchner, Florian Kofler, Michael Mayinger, et al.
Neuro-Oncology|June 13, 2024
Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic targetOphélie Renoult, Mélanie Laurent-Blond, Hala Awada, et al.
Pageof 315